Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atsushi Obata

Showing results (11-20 of 81) with videos related to

Pageof 9
Sort By:
Neuropeptides|May 27, 2018
An insurmountable NPY Y5 receptor antagonist exhibits superior anti-obesity effects in high-fat diet-induced obese miceYumiko Fukasaka, Hirohide Nambu, Hideki Tanioka, et al.
International Journal of Molecular Sciences|April 3, 2021
Unexpected Pleiotropic Effects of SGLT2 Inhibitors: Pearls and Pitfalls of This Novel Antidiabetic ClassHideaki Kaneto, Atsushi Obata, Tomohiko Kimura, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|March 30, 2021
Renal cell carcinoma sharply captured by imaging technology at an early stage in a hemodialysis patient: Usefulness of noninvasive monochrome superb microvascular imagingRie Ohsawa, Hiroyuki Kadoya, Atsushi Obata, et al.
Nuclear Medicine and Biology|July 2, 2003
Production of therapeutic quantities of (64)Cu using a 12 MeV cyclotronAtsushi Obata, Shingo Kasamatsu, Deborah W McCarthy, et al.
Magnetic Resonance Imaging|March 17, 2016
Gd-EOB-DTPA-enhanced-MR imaging in the inflammation stage of nonalcoholic steatohepatitis (NASH) in miceTomomi Yamada, Atsushi Obata, Yuto Kashiwagi, et al.
Journal of Diabetes|July 31, 2015
Appropriate therapy for type 2 diabetes mellitus in view of pancreatic β-cell glucose toxicity: "the earlier, the better"Hideaki Kaneto, Taka-Aki Matsuoka, Tomohiko Kimura, et al.
Current Medicinal Chemistry|July 1, 2016
Promising Diabetes Therapy Based on the Molecular Mechanism for Glucose Toxicity: Usefulness of SGLT2 Inhibitors as well as Incretin-Related DrugsHideaki Kaneto, Atsushi Obata, Masashi Shimoda, et al.
Journal of Diabetes|October 19, 2016
Beneficial effects of sodium-glucose cotransporter 2 inhibitors for preservation of pancreatic β-cell function and reduction of insulin resistanceHideaki Kaneto, Atsushi Obata, Tomohiko Kimura, et al.
Biomedicines|April 23, 2022
Molecular Mechanism of Pancreatic β-Cell Failure in Type 2 Diabetes MellitusHideaki Kaneto, Tomohiko Kimura, Masashi Shimoda, et al.
Biochemical and Biophysical Research Communications|October 28, 2015
Protective effects of SGLT2 inhibitor luseogliflozin on pancreatic β-cells in obese type 2 diabetic db/db miceSeizo Okauchi, Masashi Shimoda, Atsushi Obata, et al.
Pageof 9

Showing results (11-20 of 81) with videos related to

Sort By:
Pageof 9
Neuropeptides|May 27, 2018
An insurmountable NPY Y5 receptor antagonist exhibits superior anti-obesity effects in high-fat diet-induced obese miceYumiko Fukasaka, Hirohide Nambu, Hideki Tanioka, et al.
International Journal of Molecular Sciences|April 3, 2021
Unexpected Pleiotropic Effects of SGLT2 Inhibitors: Pearls and Pitfalls of This Novel Antidiabetic ClassHideaki Kaneto, Atsushi Obata, Tomohiko Kimura, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|March 30, 2021
Renal cell carcinoma sharply captured by imaging technology at an early stage in a hemodialysis patient: Usefulness of noninvasive monochrome superb microvascular imagingRie Ohsawa, Hiroyuki Kadoya, Atsushi Obata, et al.
Nuclear Medicine and Biology|July 2, 2003
Production of therapeutic quantities of (64)Cu using a 12 MeV cyclotronAtsushi Obata, Shingo Kasamatsu, Deborah W McCarthy, et al.
Magnetic Resonance Imaging|March 17, 2016
Gd-EOB-DTPA-enhanced-MR imaging in the inflammation stage of nonalcoholic steatohepatitis (NASH) in miceTomomi Yamada, Atsushi Obata, Yuto Kashiwagi, et al.
Journal of Diabetes|July 31, 2015
Appropriate therapy for type 2 diabetes mellitus in view of pancreatic β-cell glucose toxicity: "the earlier, the better"Hideaki Kaneto, Taka-Aki Matsuoka, Tomohiko Kimura, et al.
Current Medicinal Chemistry|July 1, 2016
Promising Diabetes Therapy Based on the Molecular Mechanism for Glucose Toxicity: Usefulness of SGLT2 Inhibitors as well as Incretin-Related DrugsHideaki Kaneto, Atsushi Obata, Masashi Shimoda, et al.
Journal of Diabetes|October 19, 2016
Beneficial effects of sodium-glucose cotransporter 2 inhibitors for preservation of pancreatic β-cell function and reduction of insulin resistanceHideaki Kaneto, Atsushi Obata, Tomohiko Kimura, et al.
Biomedicines|April 23, 2022
Molecular Mechanism of Pancreatic β-Cell Failure in Type 2 Diabetes MellitusHideaki Kaneto, Tomohiko Kimura, Masashi Shimoda, et al.
Biochemical and Biophysical Research Communications|October 28, 2015
Protective effects of SGLT2 inhibitor luseogliflozin on pancreatic β-cells in obese type 2 diabetic db/db miceSeizo Okauchi, Masashi Shimoda, Atsushi Obata, et al.
Pageof 9